Welcome to our Land of Opportunity
in its 30th celebratory year

Our core promise to be a ‘Service Pharma’ business
that does not compete with its customers means
we maximise the opportunity without distraction

Worldwide compliance and our no compromise
quality standards give real reassurance to our
global customer base

To all our potential customers
please know that nearly all
collaborators on our journey
remain customers to this day

Previous Next

Neuland is a no-compromise, API manufacturing service provider, offering worldwide compliant manufacturing facilities to its customers that it guarantees not to compete with in finished product.


Neuland’s core business and operational expertise has been manufacturing and marketing of active pharmaceutical ingredients (APIs). Neuland has become a preferred and reliable source of supply for several leading pharmaceutical companies worldwide.


Neuland’s Custom Manufacturing Solutions (CMS) derives from its proven expertise in manufacturing at varied scales, a deep understanding of complex chemistry and manufacturing facilities compliant with the guidelines of the leading regulatory authorities and EHS.


Neuland’s peptide synthesis services include production of peptides from milligrams to multi-kilogram scale by standard sequential chemical peptide synthesis and segment condensation strategies.


Currently celebrating it's 30th year, Neuland is at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company’s technical and scientific teams provide reliable solutions and services to the global pharmaceutical industry.

Meet Us

Thank you to everyone who visited our stand at CPhI Worldwide. Please check back here to see when and where we'll be exhibiting next.

Building a Successful Corporate Culture in Pharma

Posted on November 17, 2014 by

I’ve written before about aspects of Neuland’s corporate culture that directly affect our clients, such as our quality focus and our environmental waste mitigation of processing chemicals. I’ve also dropped…